Veracyte Inc (NAS:VCYT)
$ 31.685 1.265 (4.16%) Market Cap: 2.43 Bil Enterprise Value: 2.12 Bil PE Ratio: 0 PB Ratio: 2.15 GF Score: 83/100

Veracyte Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 01:40PM GMT
Release Date Price: $35.52 (+3.26%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everyone. This is Matt Sykes, Senior Life Sciences Tools and Diagnostics analyst at Goldman Sachs. And I have the pleasure of welcoming the Veracyte management team to our conference.

With us today, we have Bonnie Anderson, the Executive Chairperson; and Marc Stapley, the Chief Executive Officer from Veracyte. Thank you both for joining us. We're really happy to have you here.

Marc A. Stapley
Veracyte, Inc. - CEO

Thank you, Matt. Pleasure to be here.

Matthew Carlisle Sykes;Marc A. Stapley
Goldman Sachs Group, Inc., Research Division - Research Analyst;

Great. Maybe there's been a lot of things going on with Veracyte lately. A lot of exciting news. You guys have been very busy. I thought maybe what we'd start out, Marc, if you can kind of take us through sort of a bit of the history and the journey that Veracyte has been going through, leading us up to where we are today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot